Enovis (ENOV) EPS (Basic) Growth (1y) (2011 - 2026)
Analysis
Enovis (ENOV) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.92 Bn | 176.31 Bn | 7.27 Bn | -47.75% |
| 2 | Intuitive Surgical | 127.64 Bn | 122.42 Bn | 1.96 Bn | 25.48% |
| 3 | Medtronic | 117.92 Bn | 109.10 Bn | 6.34 Bn | 41.56% |
| 4 | Stryker | 105.39 Bn | 101.91 Bn | 4.50 Bn | 43.85% |
| 5 | Boston Scientific | 64.88 Bn | 64.34 Bn | 3.85 Bn | 14.55% |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.66 Bn | 1.35 Bn | -25.84% |
| 7 | Alcon | 33.24 Bn | 31.79 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.12 Bn | 30.18 Bn | 830.00 Mn | 42.13% |
| 9 | Steris | 20.83 Bn | 20.35 Bn | 684.20 Mn | 13.85% |
| 10 | Enovis | 1.08 Bn | 1.06 Bn | 359.25 Mn | 97.19% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 97.19% |
| Apr 3, 2026 | 84.97% |
| Dec 31, 2025 | 28.31% |
| Oct 3, 2025 | -1,678.19% |
| Jul 4, 2025 | -89.56% |
| Apr 4, 2025 | 25.33% |
| Dec 31, 2024 | -22,606.62% |
| Sep 27, 2024 | -978.70% |
| Jun 28, 2024 | -87.46% |
| Mar 29, 2024 | -208.17% |
| Dec 31, 2023 | 107.92% |
| Sep 29, 2023 | 95.76% |
| Jun 30, 2023 | -112.65% |
| Mar 31, 2023 | -252.41% |
| Dec 31, 2022 | -6,301.12% |
| Sep 30, 2022 | -351.92% |
| Jul 1, 2022 | 154.92% |
| Apr 1, 2022 | -31.76% |
| Dec 31, 2021 | 99.51% |
| Oct 1, 2021 | 65.83% |